Skip to main content
. 2019 May 8;14:841–848. doi: 10.2147/CIA.S201615

Table 1.

Baseline characteristics and outcomes in patients before and after the SMARTIE screen was implemented

Pre-SMARTIE (n=117) SMARTIE (n=117) χ2 or t p*
Age, mean±SD 81.2±7.4 83.3±5.7 −2.45 0.015*
Gender (Male), n(%) 68 (58.1) 71 (60.7) 0.16 0.69
Screening outcomes
Cognitive deficits, n(%) 19 (16.2) 42 (35.9) 11.73 0.001*
Depressive symptoms, n(%) 5 (4.3) 18 (15.4) 8.15 0.004*
Frailty symptoms, n(%) 6 (5.1) 17 (14.5) 5.73 0.017*
TAVI characteristics
General anesthesia, n(%) ǂ 116 (99.1) 27 (23.1) 142.4 <0.001*
TAVI urgency, n(%) ǂǂ 21 (17.9) 12 (10.3) 2.86 0.09
Procedural outcomes
Postoperative delirium, n(%) 16 (13.7) 7 (6.0) 3.91 0.048*
Stroke/transient ischemic attack, n(%) 4 (3.4) 7 (6.0) 0.86 0.35
Procedural complications, n(%) 22 (18.8) 24 (20.5) 0.11 0.74
Hospital length of stay, mean±SD 11.5±23.7 5.4±6.4 2.67 0.008*
30-day mortality, n(%) 9 (7.7) 4 (3.4) 2.04 0.15

Notes: ǂGeneral anesthesia compared to the use of local anesthesia with conscious sedation. ǂǂUrgent TAVI (including emergency and salvage surgery) compared the pre-planned procedure. *p significance: p<0.05.

Abbreviation: TAVI, transcatheter aortic valve implantation.